Our findings suggest that ASPM is a key regulator with an important role in promoting RT resistance in non‐small cell lung cancer, and that suppressing or blocking its expression could be worth exploring as therapy for a variety of RT‐resistant cancers. This evidence concerns the gene ASPM and cancer.